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We  report  the  case  of  a  37-year-old  man  with  hypertrophic  cardiomyopathy.  Echocardio-
graphy  showed  a  left  ventricular  hypertrophy  (LVH)  on  the  septal  area  (25  mm),  without
intraventricular  obstruction  or  systolic  anterior  motion  of  the  mitral  valve.  Myocardial
contrast  echocardiography  showed  an  unusual  capture  of  the  contrast  in  the  anteroseptal
wall  of  the  left  ventricle,  5  minutes  after  injection  of  Sonovue® (Bracco  Diagnostics,  Inc.,
Princeton,  NJ,  USA;  Fig.  1).
Two  weeks  later,  magnetic  resonance  imaging  (MRI)  was  performed  to  conﬁrm  the  LVH
predominantly  on  the  septal  area  (25  mm).  Myocardial  mass  was  335  g.  Delayed  enhance-
ment  MRI  studies  (10  minutes  after  gadolinium  injection)  showed  a  delay-enhancement  on
the  septal  wall  of  the  left  ventricle,  with  an  excellent  topographic  match  with  the  abnor-
mal  contrast  retention  seen  on  echocardiography.  The  late  enhancement  was  patchy  and
located  predominantly  in  the  subendocardium  and  not  in  the  intramyocardium,  which  is
more  usual  in  LVH  (Fig.  2).  To  rule  out  ischaemic  cardiopathy,  cardiac  computed  tomography
was  performed,  which  was  normal.
Delayed  enhancement  MRI  studies  can  show  late  myocardial  enhancement  in  hyper-résonance
magnétique  ;
Fibrose  myocardique  ;
Cardiomyopathie
hypertrophique
trophic  cardiomyopathy,  especially  on  the  septal  wall,  corresponding  to  ﬁbrosis.  Although
the  use  of  delayed  enhancement  MRI  in  the  diagnosis  of  myocardial  ﬁbrosis  has
been  well  documented  in  the  literature,  similar  contrast  enhancement  areas  seen  on
a  contrast  echocardiography  and  compared  with  MRI  have  not  been  reported.  Late
Abbreviations: LVH, left ventricular hypertrophy; MRI, magnetic resonance imaging.
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Figure 2. MRI showing delay-enhancement (arrows) on the sep-
tal wall of the left ventricle, with an excellent topographic match
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concerning  this  article.Figure 1. Myocardial contrast echocardiography showing (arrows)
unusual capture of contrast in the anteroseptal wall of the left
ventricle, 5 minutes after injection.
enhancement  of  microbubbles  with  myocardial  echocar-
diography  has  already  been  used  in  the  detection  and
quantiﬁcation  of  myocardial  infarct  scars.
We  believe  that  contrast  echocardiography  may  have
potential  value  for  the  detection  of  myocardial  ﬁbrosis  in
LVH.ith the abnormal contrast retention seen on echocardiography.
he late enhancement was patchy and located predominantly in
he subendocardium.
